Possible neurophysiological markers of genetic predisposition to Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 9, Issue 5, 1998, Pages 267-273

  Ponomareva, N V ^a   Fokin, V F ^a   Selesneva, N D ^a   Voskresenskaia, N I ^a  

^a BRAIN RESEARCH INSTITUTE   (Russian Federation)

Author keywords

Ageing; Alzheimer's disease; Genetic predisposition; Visual evoked potentials

Indexed keywords

AMYLOID BETA PROTEIN;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; EVOKED VISUAL RESPONSE; GENETIC PREDISPOSITION; HUMAN; LATENT PERIOD; NERVE DEGENERATION; NEUROPSYCHOLOGY; PRIORITY JOURNAL; RELATIVE;

ADULT; AGE FACTORS; AGING; ALZHEIMER DISEASE; EVOKED POTENTIALS, VISUAL; FAMILY HEALTH; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REACTION TIME;

EID: 0031845718     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017071     Document Type: Article

References (16)

1. Amaducci L, Falcini M, Lippi A: Descriptive epidemiology and risk factors for Alzheimer's disease. Acta Neurol Scand Suppl 1992;139: 21-25.
2. St. George-Hyslop PH, Tanzi RE, Polinsky RJ, et al: The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 1987;235:885-890.
3. Mullan M, Crawford F: Genetic and molecular advances in Alzheimer's disease. Trends Neurosci 1993;16:398-403.
4. Harding GF, Wright CE, Orwin A: Primary presenilc dementia. The use of visual evoked potential as a diagnostic indicator. Br J Psychiatry 1985;147:532-539.
5. McKhann G, Drachman D, Folstein M, Katzman R, et al: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Forces on Alzheimer's Disease. Neurology 1984;34:933-944.
6. Visser SL, Stam FC, Tilburg W, et al: Visual evoked response in senile and presenile dementia. Electroencephalogr Clin Neurophysiol 1976;40:385-392.
7. Zenkov LR, Ronkin MA: Functional Diagnostics of Nervous Disease (in Russian). Moscow, Medicine, 1991.
8. Ponomareva NV, Selesneva ND, Voskresenskaia NI: Correlation between the changes of evoked and DC brain potentials and the emotional disturbances in Alzheimer's disease (in Russian). J Neuropathol Psychiatry 1989;89: 92-97.
9. Moore NC, Tucker KA, Jann MW, et al: Flash P2 delay is a probable biological marker of primary degenerative dementia of the Alzheimer type. Clinical neuropharmacology. Proc 18th Collegium Int Neuropharmacol Congr. 1992; 15:291B.
10. Gottfries CG, Jungbjer B, Karlsson I, Svennerholm L: Reduction in membrane proteins and lipids in basal ganglia of Alzheimer disease patients. Alzheimer Dis Assoc Disord 1996;10: 77-81.
11. Gottfries CT: Alzheimer's disease. A critical review. Compr Gerontol 1988;2(1):47-62.
12. LaFerla FM: The Alzheimer's beta-amyloid peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Behav Pharmacol Suppl 1995;6:55.
13. Seubert P, Larson J, Oliver M, et al: Stimulation of MMDA receptors induces proteolysis of spectrin in hippocampus. Brain Res 1988;460: 189-194.
14. Beyreuther K, Pollwein P, Multhaup G, et al: Regulation and expression of the Alzheimer's beta/A4 amyloid protein precursor in health, disease and Down's syndrome. Ann NY Acad Sci 1993;695:91-102.
15. Fokin VF, Ponomareva NV, Orlov ON, et al: Relations between electricity reactions of the brain and lipid peroxidation in patients with pathological ageing (in Russian). Bull Exp Biol Med 1989;54:682-684.
16. Richardson JS: Free radicals in the genesis of Alzheimer's disease. Ann NY Acad Sci 1993; 695:91-102.